Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
Author links open overlay panelAuthors: LuisPenarrubiaaMariaRuizaRobertoPorcoaSonia N.RaobMartíJuanola-FalgaronaaDavideManisserocMartaLópez-FontanalsaJosepParejaa
Show more
https://doi.org/10.1016/j.ijid.2020.06.027
Abstract
Objectives
In this study, five SARS-CoV-2 PCR assay panels were evaluated against the accumulated genetic variability of the virus to assess the effect on sensitivity of the individual assays.
Design or methods
As of week 21, 2020, the complete set of available SARS-CoV-2 genomes from GISAID and GenBank databases were used in this study. SARS-CoV-2 primer sequences from publicly available panels (WHO, CDC, NMDC, and HKU) and QIAstat-Dx were included in the alignment, and accumulated genetic variability affecting any oligonucleotide annealing was annotated.